The Toll-like receptor 9 signalling pathway regulates MR1-mediated bacterial antigen presentation in B cells

Jianyun Liu, Randy Brutkiewicz

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Mucosal-associated invariant T (MAIT) cells are conserved T cells that express a semi-invariant T-cell receptor (Vα7.2 in humans and Vα19 in mice). The development of MAIT cells requires the antigen-presenting MHC-related protein 1 (MR1), as well as commensal bacteria. The mechanisms that regulate the functional expression of MR1 molecules and their loading with bacterial antigen in antigen-presenting cells are largely unknown. We have found that treating B cells with the Toll-like receptor 9 (TLR9) agonist CpG increases MR1 surface expression. Interestingly, activation of TLR9 by CpG-A (but not CpG-B) enhances MR1 surface expression. This is limited to B cells and not other types of cells such as monocytes, T or natural killer cells. Knocking-down TLR9 expression by short hairpin RNA reduces MR1 surface expression and MR1-mediated bacterial antigen presentation. CpG-A triggers early endosomal TLR9 activation, whereas CpG-B is responsible for late endosomal/lysosomal activation of TLR9. Consistently, blocking endoplasmic reticulum to Golgi protein transport, rather than lysosomal acidification, suppressed MR1 antigen presentation. Overall, our results indicate that early endosomal TLR9 activation is important for MR1-mediated bacterial antigen presentation.

Original languageEnglish (US)
JournalImmunology
DOIs
StateAccepted/In press - 2017

Fingerprint

Toll-Like Receptor 9
Bacterial Antigens
Antigen Presentation
B-Lymphocytes
Membrane Proteins
Proteins
Natural Killer T-Cells
Protein Transport
Antigen-Presenting Cells
T-Cell Antigen Receptor
Endoplasmic Reticulum
Small Interfering RNA
Monocytes
Bacteria
T-Lymphocytes
Antigens

Keywords

  • Antigen presentation/processing
  • B cells
  • Bacterial
  • Signal transduction
  • Toll-like receptors

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

@article{463e8a6da6ad451288d3e1f571d0234a,
title = "The Toll-like receptor 9 signalling pathway regulates MR1-mediated bacterial antigen presentation in B cells",
abstract = "Mucosal-associated invariant T (MAIT) cells are conserved T cells that express a semi-invariant T-cell receptor (Vα7.2 in humans and Vα19 in mice). The development of MAIT cells requires the antigen-presenting MHC-related protein 1 (MR1), as well as commensal bacteria. The mechanisms that regulate the functional expression of MR1 molecules and their loading with bacterial antigen in antigen-presenting cells are largely unknown. We have found that treating B cells with the Toll-like receptor 9 (TLR9) agonist CpG increases MR1 surface expression. Interestingly, activation of TLR9 by CpG-A (but not CpG-B) enhances MR1 surface expression. This is limited to B cells and not other types of cells such as monocytes, T or natural killer cells. Knocking-down TLR9 expression by short hairpin RNA reduces MR1 surface expression and MR1-mediated bacterial antigen presentation. CpG-A triggers early endosomal TLR9 activation, whereas CpG-B is responsible for late endosomal/lysosomal activation of TLR9. Consistently, blocking endoplasmic reticulum to Golgi protein transport, rather than lysosomal acidification, suppressed MR1 antigen presentation. Overall, our results indicate that early endosomal TLR9 activation is important for MR1-mediated bacterial antigen presentation.",
keywords = "Antigen presentation/processing, B cells, Bacterial, Signal transduction, Toll-like receptors",
author = "Jianyun Liu and Randy Brutkiewicz",
year = "2017",
doi = "10.1111/imm.12759",
language = "English (US)",
journal = "Immunology",
issn = "0019-2805",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - The Toll-like receptor 9 signalling pathway regulates MR1-mediated bacterial antigen presentation in B cells

AU - Liu, Jianyun

AU - Brutkiewicz, Randy

PY - 2017

Y1 - 2017

N2 - Mucosal-associated invariant T (MAIT) cells are conserved T cells that express a semi-invariant T-cell receptor (Vα7.2 in humans and Vα19 in mice). The development of MAIT cells requires the antigen-presenting MHC-related protein 1 (MR1), as well as commensal bacteria. The mechanisms that regulate the functional expression of MR1 molecules and their loading with bacterial antigen in antigen-presenting cells are largely unknown. We have found that treating B cells with the Toll-like receptor 9 (TLR9) agonist CpG increases MR1 surface expression. Interestingly, activation of TLR9 by CpG-A (but not CpG-B) enhances MR1 surface expression. This is limited to B cells and not other types of cells such as monocytes, T or natural killer cells. Knocking-down TLR9 expression by short hairpin RNA reduces MR1 surface expression and MR1-mediated bacterial antigen presentation. CpG-A triggers early endosomal TLR9 activation, whereas CpG-B is responsible for late endosomal/lysosomal activation of TLR9. Consistently, blocking endoplasmic reticulum to Golgi protein transport, rather than lysosomal acidification, suppressed MR1 antigen presentation. Overall, our results indicate that early endosomal TLR9 activation is important for MR1-mediated bacterial antigen presentation.

AB - Mucosal-associated invariant T (MAIT) cells are conserved T cells that express a semi-invariant T-cell receptor (Vα7.2 in humans and Vα19 in mice). The development of MAIT cells requires the antigen-presenting MHC-related protein 1 (MR1), as well as commensal bacteria. The mechanisms that regulate the functional expression of MR1 molecules and their loading with bacterial antigen in antigen-presenting cells are largely unknown. We have found that treating B cells with the Toll-like receptor 9 (TLR9) agonist CpG increases MR1 surface expression. Interestingly, activation of TLR9 by CpG-A (but not CpG-B) enhances MR1 surface expression. This is limited to B cells and not other types of cells such as monocytes, T or natural killer cells. Knocking-down TLR9 expression by short hairpin RNA reduces MR1 surface expression and MR1-mediated bacterial antigen presentation. CpG-A triggers early endosomal TLR9 activation, whereas CpG-B is responsible for late endosomal/lysosomal activation of TLR9. Consistently, blocking endoplasmic reticulum to Golgi protein transport, rather than lysosomal acidification, suppressed MR1 antigen presentation. Overall, our results indicate that early endosomal TLR9 activation is important for MR1-mediated bacterial antigen presentation.

KW - Antigen presentation/processing

KW - B cells

KW - Bacterial

KW - Signal transduction

KW - Toll-like receptors

UR - http://www.scopus.com/inward/record.url?scp=85021414651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021414651&partnerID=8YFLogxK

U2 - 10.1111/imm.12759

DO - 10.1111/imm.12759

M3 - Article

JO - Immunology

JF - Immunology

SN - 0019-2805

ER -